Skip to content

Clinical trials

Phase 3 Obesity trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 3 Country / region: Bulgaria Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20111
20182
20221
20233
20258
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11
Active, not recruiting8
Completed6
Not yet recruiting2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S15
Amgen3
Kailera3
Boehringer Ingelheim2
Eli Lilly and Company2
Pfizer2
AstraZeneca1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity29
Overweight16
Diabetes Mellitus, Type 26
Diabetes Mellitus2
Heart Failure2
Nutrition Disorders2
Osteoarthritis, Knee2
Atherosclerosis1
Body Weight1
Colitis, Ulcerative1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.